RNATICS
PrivateLast Round
Grant
Feb 20, 2026
Total Funding Raised
$11.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RNATICS is a drug discovery company that develops RNA-based therapeutic methods intended for the treatment of severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNATICS Comparables
Compare RNATICS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpliSense | 79% | |
| Novartis | 69% | |
| Avalyn Pharma | 69% | |
RNATICS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2026 | ||||
| Accelerator | Jun 26, 2024 | ||||
| Grant | Jan 13, 2022 | ||||
| Spinoff | Jan 1, 2021 |
RNATICS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technical University of Munich | Spinoff |
| Munich Accelerator Life Sciences & Medicine | Accelerator |
| BioM AG Munich BioTech Development | Accelerator |
| Federal Ministry of Research, Technology and Space | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 67% MoM, reaching 1.9K.
- May 15, 2026
Monthly visitors increased 276% MoM.
RNATICS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RNATICS's valuation, stock price, and market status.